Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer

Recruiting now

Conditions studied: Ovarian Cancer, Cognitive Change

In brief

The purpose of this research is to assess several components of cognition in patients recently diagnosed with advanced epithelial ovarian cancer and who will be undergoing neoadjuvant chemotherapy for treatment of the cancer. 18 participants will be enrolled and can expect to be on study for approximately 10 months.

Key facts

Study ID
NCT07125209
Run by
University of Wisconsin, Madison
People needed
18
Starts
2026-04-28
Expected to finish
2027-12-01
Last updated by the study team
2026-05-05

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.